Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000869571 | SCV001011009 | likely benign | Hypertrophic cardiomyopathy | 2024-12-17 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001111275 | SCV001268821 | uncertain significance | Hypertrophic cardiomyopathy 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Illumina Laboratory Services, |
RCV003320222 | SCV001268822 | uncertain significance | Myosin storage myopathy | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Illumina Laboratory Services, |
RCV001113280 | SCV001271042 | benign | MYH7-related skeletal myopathy | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Color Diagnostics, |
RCV001181795 | SCV001347021 | likely benign | Cardiomyopathy | 2018-12-16 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001181795 | SCV002042250 | likely benign | Cardiomyopathy | 2020-02-19 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV001823748 | SCV002073465 | likely benign | not specified | 2022-01-19 | criteria provided, single submitter | clinical testing | This synonymous variant has an entry in ClinVar (701138) NM_000257.4 (MYH7): c.1368C>T (p.Phe456=) and has occurred in GnomAD with a total MAF of 0.0045% and highest MAF of 0.0580% in the East Asian population. This position is conserved. In silico splicing algorithm was unavailable, however it is not predicted to impact splicing due to its distance from the splice site. No functional studies were performed to confirm this prediction. The variant has previously been reported in a patient affected with hypertrophic cardiomyopathy (PMID: 27841901). Considering the above evidence, this variant has been classified as Likely Benign. |
All of Us Research Program, |
RCV001181795 | SCV005431151 | likely benign | Cardiomyopathy | 2024-03-24 | criteria provided, single submitter | clinical testing |